Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002714
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

Who this might be right for
Lymphoma
Stanford University
Early research (Phase 1)Study completedNCT01485952
What this trial is testing

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

Who this might be right for
Huntington Disease
Siena Biotech S.p.A. 55
Large-scale testing (Phase 3)UnknownNCT01731548
What this trial is testing

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

Who this might be right for
Carcinoma of LungSmall CellLimited Stage
Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT05332561
What this trial is testing

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Who this might be right for
Early-stage Breast Cancer
German Cancer Research Center 240
Testing effectiveness (Phase 2)Looking for participantsNCT07402473
What this trial is testing

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

Who this might be right for
HER2-positive Early-stage Breast Cancer
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT01406769
What this trial is testing

Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy

Who this might be right for
LymphedemaPerioperative/Postoperative ComplicationsStage IA Vulvar Cancer AJCC v7+7 more
Gynecologic Oncology Group 120
Not applicableLooking for participantsNCT06544083
What this trial is testing

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 600
Testing effectiveness (Phase 2)Study completedNCT00003129
What this trial is testing

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Eastern Cooperative Oncology Group 75
Testing effectiveness (Phase 2)Study completedNCT00753103
What this trial is testing

Anti-Cytokine Therapy for Vasculitis

Who this might be right for
Wegener's GranulomatosisRenal Limited VasculitisMicroscopic Polyangiitis
University Hospital Birmingham NHS Foundation Trust 37
Not applicableStudy completedNCT02129686
What this trial is testing

A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients

Who this might be right for
Taxane-induced Peripheral NeuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Early-Stage Breast Carcinoma+3 more
Dana-Farber Cancer Institute 57
Early research (Phase 1)UnknownNCT03788083
What this trial is testing

Intratumoral TriMix Injections in Early Breast Cancer Patients

Who this might be right for
Breast Cancer FemaleEarly-stage Breast Cancer
Universitair Ziekenhuis Brussel 36
Not applicableLooking for participantsNCT06349642
What this trial is testing

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Who this might be right for
Early Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more
Mayo Clinic 324
Large-scale testing (Phase 3)Study completedNCT03907241
What this trial is testing

CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL

Who this might be right for
Primary Immunodeficiency
Octapharma 27
Not applicableUnknownNCT06251726
What this trial is testing

Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 310
Early research (Phase 1)Study completedNCT01804335
What this trial is testing

CD5789 in Early Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02046733
What this trial is testing

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

Who this might be right for
Limited Stage Small Cell Lung CancerSmall Cell Lung Cancer
ETOP IBCSG Partners Foundation 222
Testing effectiveness (Phase 2)Ended earlyNCT01138748
What this trial is testing

Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers

Who this might be right for
Inoperable Early Stage Non-small Cell Lung Cancer
University Hospital, Ghent 5
Testing effectiveness (Phase 2)Study completedNCT02838225
What this trial is testing

DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 300
Large-scale testing (Phase 3)Looking for participantsNCT07502820
What this trial is testing

The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

Who this might be right for
Breast CancerAdjuvant Drug Therapy
Karolinska Institutet 1,100
Not applicableLooking for participantsNCT07042724
What this trial is testing

Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study

Who this might be right for
Lung Cancer (NSCLC)
Universita di Verona 324
Next Page